A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Head and Neck Squamous Cell Carcinoma|Advanced Breast Cancer|Advanced Melanoma
Interventions: DRUG: CyPep-1|DRUG: Pembrolizumab 25 MG/ML [KEYTRUDA®]
Sponsor: Cytovation AS
Collaborators: Merck Sharp & Dohme LLC